"The Effect of The Combination Therapy of Statin and SGLT2i in The Treatment of Ischemic Heart Disease"

Recruiting now

Conditions studied: 2 Drugs Are Statin and SGLT2i

In brief

correlate the serum level of statin and SGLT2i when given as polytherapy with HPLC in ischemic heart failure patients and their laboratory tests (cholesterol, LDL, HDL and TG...)

Key facts

Study ID

NCT06520891

Run by

Fayoum University

People needed

90

Starts

2024-06-01

Expected to finish

2025-12-30

Last updated by the study team

2025-09-11

Who can join

Age: 50 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• we include patients established ischemic heart failure seen by a primary care provider to diagnose ischemic heart disease,
• They assessed the use of statin with SGLT2i.

You may not qualify if…

• We exclude patients with
• liver dysfunction.
• renal dysfunction.
• fungal infection.
• coagulation disorder.
• Pts using drugs that interact with SGLT2i.
• patients that will refuse to be enrolled in the Study or refuse to write informed consent.

Where it is running

• Asmaa mohamed abdelkader — Al Fayyum, Faiyum Governorate, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.